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Abstract
Background: Medications targeting stroke risk factors have shown good efficacy, yet adherence is suboptimal. A
lack of underlying theory may contribute to the ineffectiveness of eliciting or sustaining behaviour change in many
existing interventions targeting medication adherence in stroke. Intervention effectiveness and implementation could
be enhanced by consideration of evidence base and theory to drive development. The purpose of this study
is to identify appropriate components for a theory-driven and evidence-based medication adherence intervention for
stroke survivors.
Methods: The Behaviour Change Wheel (BCW), a guide to intervention development, informed our systematic process
of intervention development. Our earlier systematic review had identified important determinants of medication
adherence that were mapped into the Theoretical Domains Framework (TDF), with Knowledge, Beliefs about
consequences and Emotions found to be more influential. Utilising the BCW facilitated selection of intervention
options and behaviour change techniques (BCTs); the active ingredients within an intervention. To further refine
BCT selection, APEASE criteria were employed, allowing evaluation of potential BCTs within context: The National
Health Service (NHS), United Kingdom (UK).
Results: Five intervention functions (Education, Persuasion, Training, Environmental Restructuring and Enablement) and
five policy categories (Communication/marketing, Guidelines, Regulation, Environmental/social planning and
Service provision) were identified as potential intervention options, underpinned by our systematic review findings.
Application of APEASE criteria led to an initial pool of 21 BCTs being reduced to 11 (e.g. Habit Formation, Information
about Health Consequences and Action Planning) identified as potential intervention components that would
both be feasible and directly target the underlying determinants of stroke survivors’ medication adherence.
Conclusions: Careful consideration of underlying evidence and theory to drive intervention design, facilitated
by the BCW, enabled identification of appropriate intervention components. BCTs including Habit Formation,
Information about Health Consequences and Self-monitoring of Behaviour were considered potentially effective and
appropriate to deliver within the NHS. Having reduced the pool of potential intervention components to a
manageable number, it will now be possible to explore the perceived acceptability of selected BCTs in interviews with
stroke survivors and healthcare professionals. This approach to intervention development should be generalisable to
other chronic conditions and areas of behaviour change (e.g. exercise adherence).
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Background
Stroke can result in life altering and fatal consequences
[1]. In 2013, stroke was recognised as the second leading
cause of death worldwide [2], with an estimated 110,000
first or recurrent stroke in the United Kingdom (UK)
per annum [3]. Moreover, cumulative risk of a secondary
stroke is thought to be as much as 26% in the first five
years following a stroke [4]. Guidelines recommend
medications for the secondary prevention of stroke [3,
5]), including antihypertensive, blood thinning and chol-
esterol lowering medications.
It is evident that medication adherence, defined as “the
extent to which the patient’s action matches the agreed
recommendations” [6], is sub-optimal in stroke survivors
(e.g. [6, 7]), despite the efficacy of medications for risk fac-
tor control of cardiovascular conditions such as hyperten-
sion and hyperlipidaemia [8–10], with about a third of
stroke survivors considered non-adherent [11]. Many at-
tempts have been made to intervene, in an effort to im-
prove medication adherence. Unfortunately, the majority
of interventions targeting medication adherence in stroke
survivors have shown limited effectiveness [12, 13]. This
has also been the case in other chronic conditions [14].
The complexity of measuring adherence and the variabil-
ity in reasons identified for non-adherence are reflected in
results from previous intervention studies [12, 13]. This
limits the ability to know whether the intervention com-
ponents are in fact targeting true influences of medication
adherence and whether adherence is being accurately
measured. The UK Medical Research Council (MRC)
framework for designing and evaluating complex inter-
ventions has advocated systematic intervention develop-
ment, using evidence base and theory, [15] and other
frameworks for intervention development also suggest
similar, for example Intervention Mapping [16, 17]. A lack
of evidence-based selection of behaviour change tech-
niques (BCTs, the active ingredients within an interven-
tion [18]) used in the intervention may be partially
responsible for limited success to date. Therefore, this
study aimed to develop an evidence-based and theory
driven behaviour change intervention targeting medica-
tion adherence in stroke survivors.
There are numerous theories of behaviour that can
underpin intervention development [19]. However, these
theories have been subject to a number of criticisms, in-
cluding not always operationalising the constructs
clearly, not considering the context in which a behaviour
occurs, and an over emphasis on rational, deliberative
determinants [20]. The development of the Theoretical
Domains Framework (TDF) offers some response to
these criticisms, and provides a more holistic model of
behaviour to underpin intervention development [21,
22]. The TDF was developed through expert consensus.
Behaviour change professionals identified constructs
from many major behaviour change theories. The identi-
fied constructs were clustered using open and closed
sort tasks, grouping similar constructs together to form,
what the authors termed, a domain. After revisions, 14
key domains were established (Knowledge; Skills; Social/
Professional role and identity; Beliefs about capabilities;
Optimism; Beliefs about consequences; Reinforcement;
Intentions; Goals; Memory, Attention and Decision pro-
cesses; Environmental context and resources; Social in-
fluences; Emotions; & Behavioural regulation [22]).
The Behaviour Change Wheel (BCW) is a guide to
intervention development that has provided a systematic
and structured intervention development process,
underpinned by theory: the TDF [22, 23]. This has en-
hanced intervention development processes, such that
researchers are able to make evidence-based selection of
intervention components (including BCTs, the interven-
tion’s active ingredients), ensuring that interventions tar-
get the underlying determinants of behaviour. The BCW
prescribes a process of systematically mapping under-
lying determinants of behaviour, in a series of stages, to
BCTs that are perceived to best target and influence
these determinants. Moreover, BCTs have been refined
into a taxonomy of 93 BCTs [18], providing a consistent
language to use and a resource to access a comprehen-
sive list of BCTs when developing interventions. Re-
search applying the BCW to underpin intervention
design, in other health behaviours (such as safer sex),
have shown good feasibility and acceptability of the in-
terventions, with emerging evidence to support interven-
tion effectiveness in influencing outcomes [24].
Application of literature, consideration of the context
in which the intervention will be delivered and use of
APEASE (Affordability, Practicality, Effectiveness, Ac-
ceptability, Side effects, Equity; [25]) evaluative criteria
will enhance the intervention development, outlined in
this study. Systematic reviews can assist in identifying
the evidence base for the determinants of the behaviour.
This provides foundations for later evidence-based selec-
tion of intervention components most likely to elicit
behaviour change. The evidence base for this interven-
tion development was drawn from a recent systematic
review, identifying psychological determinants of medi-
cation adherence in stroke survivors [26]. The determi-
nants identified were mapped into the domains of the
TDF, as this was the theoretical framework selected to
underpin the intervention development. The series of
steps advocated by the BCW to develop an intervention,
which align with other guidance on developing complex
interventions [15], were utilised and are described in de-
tail in the methods below. The methods also discuss
how literature, consideration of the context the interven-
tion will be delivered in and use of evaluative criteria
were utilised to ensure that components selected for the
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intervention were not only targeting the underlying de-
terminants of behaviour, but were also appropriate and
realistic to be delivered within the desired context, in
this case within the UK National Health Service (NHS).
The aim of this study was to identify appropriate com-
ponents for a theory-driven and evidence-based medica-
tion adherence intervention for stroke survivors.
Methods
The authors followed a systematic process of interven-
tion development advocated by the BCW guidance
[25], which involved a series of stages that are discussed
below and outlined in Fig. 1. This process was under-
pinned by previous research [26], that formed the initial
steps of this intervention development. Any interven-
tion development decision was based on the premise
that this intervention would be suitable for all adult
stroke survivors, except those living in long-term insti-
tutional care or those that are fully reliant on carers for
all daily tasks, as medication adherence would be
largely under the control of a carer.
Each stage followed will be discussed in more detail
below.
Stage 1: Understanding the behaviour
This stage comprises four steps (detailed in Fig. 1) that fa-
cilitate defining the public health problem in context. This
was approached by reviewing evidence to define the be-
havioural problem (Step 1), breaking this down into spe-
cific behaviours and eventually selecting one target
behaviour to focus upon (Step 2 and 3). A systematic re-
view of psychological determinants of medication adher-
ence in stroke survivors [26] supported understanding of
influences upon the behaviour (Step 4). Mapping the iden-
tified determinants into the TDF and identifying key do-
mains that were more influential to behaviour change
enabled a better understanding of what needed to change.
Stage 2: Identifying intervention options
This stage of intervention development was supported
by the Behaviour Change Wheel guidance [23, 25],
encompassing two steps. This drew on previous re-
search, whereby a systematic review identified 19 frame-
works of behaviour change that encompassed the nine
intervention functions and seven policy categories used
in the BCW [23]. Moreover, a consensus exercise under-
taken by experts in the field, linked theoretical domains
to intervention functions and subsequent policy categor-
ies well suited to facilitate the behaviour change [23, 25].
Intervention functions are defined as “broad categories
of means by which an intervention can change behav-
iour” [25] and policy categories can be understood as
“types of decisions made by authorities that help to sup-
port and enact the intervention” [25]. Use of this litera-
ture facilitated identification of relevant intervention
functions (Step 1) and policy categories (Step 2). Exten-
sive work has been carried out to identify the interven-
tion functions and policy categories most likely to bring
about change, when linked to underlying theoretical do-
mains form the TDF [25]. A consideration of the likely
services (e.g. health, voluntary, social etc.) that the inter-
vention could be implemented into also facilitated
choice of intervention functions and realistic policy
categories. Application of APEASE [25] provided evalu-
ative criteria and also narrowed down the potential
Fig. 1 Illustrating a systematic and theory driven intervention development process. BCTTV1 – Behaviour Change Technique Taxonomy Version 1.
APEASE - Affordability, practicality, effectiveness/cost-effectiveness, acceptability, side effects, equity
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intervention functions that would be carried forward for
this intervention development.
Whilst effectiveness of an intervention is certainly im-
portant to consider during the design process, there are
other factors that are important, such as evaluation of
intervention component suitability in the intended set-
ting and social context. APEASE evaluative criteria sup-
port this broader consideration by challenging an
intervention designer to ask questions such as [25]:
 (Affordability) Is the cost of the proposed
intervention within budget?
 (Practicality) Can the intervention be delivered as
designed in the intended setting?
 (Effectiveness) How effective is the intervention?
What is the magnitude (effect size) of the
relationship between intervention and behaviour?
 (Acceptability) Is the intervention deemed
appropriate by key stakeholders?
 (Side effects) Are there any unwanted side effects
from delivering this intervention that need to be
considered?
 (Equity) Does the intervention reduce or increase
disparities between different sectors of society?
Therefore, the use of APEASE criteria supplements
the selection of intervention components through the
application of contextual criteria.
Stage 3: Identify content and implementation options
An emerging literature base from experts in the field,
identifying BCTs better suited to certain intervention
functions and underlying theoretical domains, supported
evidence-based selection of appropriate BCTs [27, 28].
In addition, extensive literature searching of current
BCTs used in interventions deemed to be effective, tar-
geting akin behaviours or patient groups, as well as
application of APEASE criteria supported BCT choice.
Affordability, practicality and acceptability were deemed
to be of particular importance in this evaluative process
by the research team, given the NHS context for imple-
mentation. To set the scene, the NHS provides universal
health coverage and it is a service in high demand, in
part because it is free at the point of use. At present, the
UK norm for length of a general practitioner (GP)
consultation is a 10-min appointment, although some
practices are able to offer longer appointments. Nurse
appointments in primary care are often longer. Commu-
nity pharmacists do not usually operate an appointment
system but offer consultations based on clinical require-
ments. HCPs such as community pharmacists are in-
creasingly enlisted to deliver interventions to enhance
healthcare. For example, pharmacists offer medication
use reviews (MURs) annually to patients and this may
offer an alternative to GP care. Specific to stroke ser-
vices, patients discharged from a secondary care setting
will often only have one or two follow up appointments
with the secondary care team before being discharged to
primary care services, where the secondary prevention
of stroke through medication use, for example, will then
be managed. BCTs found not to meet these three
APEASE criteria were not carried forward to the next
stage of intervention design.
Results
Stage 1: Understanding the behaviour
The target behaviour for this intervention is medication
adherence, defined as “the extent to which the patient’s
action matches the agreed recommendations” [6]. As
discussed earlier, up to a third of stroke survivors are
non-adherent to their medications, indicating the behav-
ioural problem for this intervention (Step 1).
The target behaviour for this intervention was further
defined as: stroke survivors taking medication at the pre-
scribed times, doses and frequencies (Step 2 and 3). A
decision was made, following consultation with a patient
and public involvement group, to target all medication
as opposed to narrowing the focus down to one medica-
tion, such as an antihypertensive. A systematic review
identifying the psychological factors that influence stroke
survivors’ medication adherence was already available
[26] (Step 4). Determinants including concerns about
medications, beliefs about medication necessity, know-
ledge about medications and negative emotions had been
identified as influential [26]. Once mapped into the TDF,
three key domains were identified as influential in be-
haviour change: ‘Knowledge’ (knowledge about medica-
tions), ‘Beliefs about consequences’ (concerns about
medications, beliefs about medication necessity) and
‘Emotions’ (negative emotions) domains.
Stage 2: Identifying intervention options
A mapping process, recommended by BCW guidance
[23, 25] was followed. This drew on previous research
[23, 25], utilised to identify the potential intervention
functions and policy categories that would target the
three theoretical domains found to be most influential to
medication adherence in stroke survivors in Stage 1. The
possible intervention functions (Step 1) and policy cat-
egories (Step 2) are displayed in Tables 1 and 2.
The use of APEASE criteria [25], along with consider-
ation of the intervention context, assisted in narrowing
down the potentially appropriate intervention functions.
Likewise, the same process was used to narrow down
the potentially appropriate policy categories. Within
Tables 1 and 2, reasons for inclusion/exclusion of the
intervention functions and policy categories are
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Table 1 Intervention functions that are appropriate to target underlying theoretical domains
TDF Domain Intervention Function Intervention Function Definitionsa Included/excluded
from next stage
Reasons for Inclusion/exclusion (against
APEASE criteria)
Knowledge Education Increasing knowledge or understanding Included Considered affordable, practical, potentially
effective, potentially acceptable, should have
limited side effects and shouldn’t create
significant issues of equity
Training Imparting skills Included Considered affordable, practical, potentially
effective, potentially acceptable, should
have limited side effects and shouldn’t
create significant issues of equity
Enablement Increasing means/reducing barriers to
increase capability (beyond education/
training) or opportunity (beyond
environmental restructuring)
Included Considered affordable, practical, potentially
effective, potentially acceptable, should
have limited side effects and shouldn’t
create significant issues of equity
Beliefs about
consequences
Education Increasing knowledge or understanding Included Considered affordable, practical, potentially
effective, potentially acceptable, should have
limited side effects and shouldn’t create
significant issues of equity
Persuasion Using communication to induce positive
or negative feelings or stimulate action
Included Considered affordable, practical, potentially
effective, potentially acceptable, should
have limited side effects and shouldn’t
create significant issues of equity
Incentivisation Creating an expectation of reward Excluded Not considered affordable, unlikely to be
acceptable to policy makers and would
possibly be impractical to incentivise over a
sustained period of time
Coercion Creating an expectation of punishment
or cost
Excluded Not considered practical to deliver (as HCPs
often want to maintain good and balanced
relationships with patients), unlikely to be
acceptable to HCPs or patients morally and
ethically, enforcing punishment or cost onto
patients will also likely have unwanted side
effects, and could reduce equity for some
sectors of the community
Emotions Persuasion Using communication to induce positive
or negative feelings or stimulate action
Included Considered affordable, practical, potentially
effective, potentially acceptable, should
have limited side effects and shouldn’t
create significant issues of equity
Incentivisation Creating an expectation of reward Excluded Not considered affordable, unlikely to be
acceptable to policy makers and would
possible be impractical to incentivise over a
sustained period of time
Coercion Creating an expectation of punishment
or cost
Excluded Not considered practical to deliver (as HCPs
often want to maintain good and balanced
relationships with patients), unlikely to be
acceptable to HCPs or patients morally and
ethically, enforcing punishment or cost onto
patients will also likely have unwanted side
effects, and could reduce equity for some
sectors of the community
Restriction Using rules to reduce the opportunity to
engage in the target behaviour (or to
increase target behaviour by reducing the
opportunity to engage in the competing
behaviour)
Excluded Not considered practical to deliver as
medicine taking can be carried out alone
and so there will be no one present to
enforce rules, unlikely to be acceptable to
patients, HCPs or policy makers as rules
often require legislation changes to be
enforceable and acted upon
Environmental
Restructuring
Changing the physical or social context Included Considered affordable, practical, potentially
effective, potentially acceptable, should
have limited side effects and shouldn’t
create significant issues of equity unless
patients do not have access to similar healthcare
services or possess similar abilities
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presented and examples for exclusion of intervention
functions and policy categories are discussed below.
Four intervention functions were not considered to be
appropriate for this intervention design (Incentivisation;
Coercion; Restriction; and Modelling). For example, Re-
striction i.e. “use rules to reduce the opportunity to en-
gage in the behaviour” [25], when considering APEASE
would likely not be acceptable or practical. Medicine
taking is often done alone and so there will be no one
there to enforce the rules or witness rule breaking,
which in turn will limit the effectiveness of this inter-
vention function. Coercion i.e. “Create an expectation of
punishment or cost” [25] seems inappropriate, within
the service the intervention would likely be implemented
(the NHS), morally and ethically (particularly as this
conflicts with HCP ethical frameworks). It is inappropri-
ate to create an expectation of punishment if patients do
not take their medicines, given that patients can have
valid reasons for not wanting to adhere to regimens such
as wanting to stop side effects. Moreover, in terms of
APEASE, it is likely not acceptable to coerce medication
adherence, and there will likely be unwanted side effects
from the use of this intervention function, potentially
causing the undesired consequence of even worse adher-
ence from patients. Likewise, Incentivisation i.e. “create
an expectation of reward” [25], has similar ethical con-
straints, in addition to potential financial constraints.
Although there is emerging evidence (both from system-
atic review and primary studies) to suggest that incenti-
visation could have utility in interventions targeting
medication adherence [29–33], these studies have pre-
dominantly been conducted within the US and have
shown promising but varying effect sizes that are not
consistently statistically significant. Within the UK NHS
context, financial and economic constraints are such
that interventions based on financial incentives are un-
likely to be adopted. Finally Modelling i.e. “provide an
example of people to aspire to or emulate” [25] was felt
to limit some practicality and possibly some equity.
The ability to emulate another’s behaviour could be
contingent on multiple other factors, such as access to
similar healthcare services and patients possessing simi-
lar abilities (cognitive, social, physical) to successfully
take their medicines in the same manner.
Two policy categories were not considered further
for this intervention design (Fiscal Measures and Le-
gislation). For example, Fiscal Measures i.e. “the use of
the tax system to reduce or increase the financial cost”
[25] is not a practical policy category to consider.
This is partly due to the fact that within the UK, resi-
dents over the age of 60 years (a category that a large
proportion of stroke survivors come under) do not pay
for prescriptions and as such an amendment to tax-
ation systems seems a less practical option. Further-
more, individuals considered to be living on low
incomes or receiving certain types of welfare benefits
(such as those unable to work due to illness) can apply
for exemptions of paying for prescriptions. In the UK,
prescription costs are also comparatively low in com-
parison to other healthcare systems such as those in
the US (£8.80 per item, which equates to US $11.85 or
€10.20), and for individuals requiring multiple pre-
scriptions regularly, there are schemes in place to re-
duce the maximum annual cost to £104. Fiscal
measures would likely require legislation changes,
something that would rely upon elected politicians’
willingness to propose such changes. There would also
be questions of affordability dependant on the eco-
nomic climate at the time of the intervention, and
thus the use of this policy category could become less
acceptable. Legislation i.e. “making or changing laws”
[25] was not practical to focus on within this project
as the process involved would be out of scope for a re-
search study.
Stage 3: Identify content and implementation options
Table 3 displays the process of systematically using an
evidence base to select potential BCTs for this interven-
tion. Careful linking of evidence base and theory, under-
pinned by the BCW [23, 25] and previous work by
Table 1 Intervention functions that are appropriate to target underlying theoretical domains (Continued)
TDF Domain Intervention Function Intervention Function Definitionsa Included/excluded
from next stage
Reasons for Inclusion/exclusion (against
APEASE criteria)
Modelling Providing an example for people to
aspire to or imitate
Excluded Not considered to be practical to deliver
as patients do not always have contact with
HCPs or other patients when collecting
prescriptions for medications, could
potentially create disparities in equity
Enablement Increasing means/reducing barriers to
increase capability (beyond education/
training) or opportunity (beyond
environmental restructuring)
Included Considered affordable, practical, potentially
effective, potentially acceptable, should have
limited side effects and shouldn’t create
significant issues of equity
APEASE Affordability, practicality, effectiveness/cost-effectiveness, acceptability, side effects, equity, HCPs Healthcare Professionals, TDF Theoretical
Domains Framework
aDefinitions from Michie, S., L. Atkins, and R. West, The Behaviour Change Wheel: A Guide to Designing Interventions. 2014, UK: Silverback Publishing
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Table 2 Identification of the potential policy categories appropriate for the intervention based on selected intervention functions
Intervention Function Policy Category Policy Category Definitiona Included/excluded
from next stage
Reasons for Inclusion/exclusion (against APEASE criteria)
Education Communication/
Marketing
Using print, electronic, telephonic or
broadcast media
Included Considered affordable, practical, potentially effective,
potentially acceptable, should have limited side effects
and shouldn’t create significant issues of equity
Guidelines Creating documents that recommend
or mandate practice. This includes all
changes to service provision
Included Considered affordable, practical, potentially effective,
potentially acceptable, should have limited side effects
and shouldn’t create significant issues of equity
Regulation Establishing rules or principles of
behaviour or practice
Excluded Not considered practical for this project as the timeline
would not allow for the process of changes to current
health practice regulations
Legislation Making or changing laws Excluded Not considered practical for this project as the timeline
would not allow for the process of changes to law
Service Provision Delivering a service Included Considered affordable, practical, potentially effective,
potentially acceptable, should have limited side effects
and shouldn’t create significant issues of equity
Persuasion Communication/
Marketing
Using print, electronic, telephonic or
broadcast media
Included Considered affordable, practical, potentially effective,
potentially acceptable, should have limited side effects
and shouldn’t create significant issues of equity
Guidelines Creating documents that recommend
or mandate practice. This includes all
changes to service provision
Included Considered affordable, practical, potentially effective,
potentially acceptable, should have limited side effects
and shouldn’t create significant issues of equity
Regulation Establishing rules or principles of
behaviour or practice
Excluded Not considered practical for this project as the timeline
would not allow for the process of changes to current
health practice regulations
Legislation Making or changing laws Excluded Not considered practical for this project as the timeline
would not allow for the process of changes to law
Service Provision Delivering a service Included Considered affordable, practical, potentially effective,
potentially acceptable, should have limited side effects
and shouldn’t create significant issues of equity
Training Guidelines Creating documents that recommend
or mandate practice. This includes all
changes to service provision
Included Considered affordable, practical, potentially effective,
potentially acceptable, should have limited side effects
and shouldn’t create significant issues of equity
Fiscal Measures Using the tax system to reduce or
increase the financial cost
Excluded Not considered practical (partially due to free prescriptions
over the age of 60 in UK, which encompasses a large
proportion of stroke survivors), unlikely to be acceptable
to policy makers who would probably need to instigate
legislation changes, potentially not affordable contingent
on the economic climate at the time of the change
Regulation Establishing rules or principles of
behaviour or practice
Excluded Not considered practical for this project as the timeline
would not allow for the process of changes to current
health practice regulations
Legislation Making or changing laws Excluded Not considered practical for this project as the timeline
would not allow for the process of changes to law
Service Provision Delivering a service Included Considered affordable, practical, potentially effective,
potentially acceptable, should have limited side effects
and shouldn’t create significant issues of equity
Environmental
Restructuring
Guidelines Creating documents that recommend
or mandate practice. This includes all
changes to service provision
Included Considered affordable, practical, potentially effective,
potentially acceptable, should have limited side effects
and shouldn’t create significant issues of equity
Fiscal Measures Using the tax system to reduce or
increase the financial cost
Excluded Not considered practical (partially due to free prescriptions
over the age of 60 in UK, which encompasses a large
proportion of stroke survivors), unlikely to be acceptable to
policy makers who would probably need to instigate
legislation changes, potentially not affordable contingent
on the economic climate at the time of the change
Regulation Establishing rules or principles of
behaviour or practice
Excluded Not considered practical for this project as the timeline
would not allow for the process of changes to current
health practice regulations
Legislation Making or changing laws Excluded Not considered practical for this project as the timeline
would not allow for the process of changes to law
Environmental/
Social Planning
Designing and/or controlling the
physical or social environment
Included Considered affordable, practical, potentially effective,
potentially acceptable, should have limited side effects and
shouldn’t create significant issues of equity
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experts in the field [27, 28] has resulted in a potential 21
BCTs that might be considered for this intervention.
Application of APEASE, as well as identifying existing
effectiveness of the BCTs within other, similar interven-
tions has enabled the selection to be narrowed down to
11 BCTs (information about health consequences (5.1);
self-monitoring of behaviour (2.3); biofeedback (2.6); in-
formation about antecedents (4.3); credible source (9:1);
self-monitoring of outcome(s) of behaviour (2.4); pros and
cons (9.2); prompts/cues (7:1); action planning (1:4);
habit formation (8:3); social support (emotional) (3.3)).
Table 4 presents all 21 BCTs, separated into BCTs that
will be included or excluded from the next stage of this
intervention development. Reasons for inclusion/exclu-
sion of each BCT are summarised in Table 4, assessed
against APEASE criteria.
Discussion
This study serves to add to existing stroke and medica-
tion adherence literature by presenting an intervention
developed using the BCW, underpinned by the TDF, and
designed in consideration of implementation into the
NHS. Eleven BCTs were identified as potential compo-
nents for his intervention. BCTs identified included
habit formation (8.4), action planning (1.4) and informa-
tion about health consequences (5.1).
Consideration of the intervention context (e.g. time
and financial pressures within the NHS), facilitated by
using APEASE evaluative criteria [25], has enhanced this
process and enabled the development of a focused inter-
vention. This process was important as there is currently
a lack of experimental evidence in the literature looking
at the effectiveness of particular BCTs targeting specific
psychological determinants of medication adherence of
stroke survivors. Moreover, inconsistencies in descrip-
tions of published interventions means that it is difficult
to establish which BCTs are more effective at targeting
medication adherence in stroke survivors. For example,
it is often difficult to identify the type of information
provision given to participants in an intervention, as
varying terms have been used for this intervention com-
ponent e.g. “an educational booklet” [34] or “reinforcing
relevant knowledge on the chronic diseases they are suf-
fering from” [35]. With the development of checklists to
support reporting of interventions, such as the Template
for Intervention Description and Replication (TIDieR)
checklist [36], clear and transparent recording of what is
included within interventions may be enhanced.
An understanding of underlying modifiable factors is
required in order to change behaviour (e.g. [37]). To
achieve this, a systematic review was used in this study
that identified potential determinants of medication ad-
herence in stroke survivors to target with intervention
[26]. The shortlisted selection of BCTs was generated
through systematic linking of determinants to interven-
tion functions, policy categories and associated BCTs,
ensuring that the intervention remains evidence-based,
theory driven and targets the known modifiable psycho-
logical influences on medication adherence in stroke
survivors. This will facilitate evaluation of the interven-
tions’ effectiveness when feasibility and pilot testing is
carried out, as identification of core intervention
Table 2 Identification of the potential policy categories appropriate for the intervention based on selected intervention functions
(Continued)
Intervention Function Policy Category Policy Category Definitiona Included/excluded
from next stage
Reasons for Inclusion/exclusion (against APEASE criteria)
Enablement Guidelines Creating documents that recommend
or mandate practice. This includes all
changes to service provision
Included Considered affordable, practical, potentially effective,
potentially acceptable, should have limited side effects
and shouldn’t create significant issues of equity
Fiscal Measures Using the tax system to reduce or
increase the financial cost
Excluded Not considered practical (partially due to free prescriptions
over the age of 60 in UK, which encompasses a large
proportion of stroke survivors), unlikely to be acceptable to
policy makers who would probably need to instigate
legislation changes, potentially not affordable contingent
on the economic climate at the time of the change
Regulation Establishing rules or principles of
behaviour or practice
Excluded Not considered practical for this project as the timeline
would not allow for the process of changes to current
health practice regulations
Legislation Making or changing laws Excluded Not considered practical for this project as the timeline
would not allow for the process of changes to law
Environmental/
Social Planning
Designing and/or controlling the
physical or social environment
Included Considered affordable, practical, potentially effective,
potentially acceptable, should have limited side effects
and shouldn’t create significant issues of equity
Service Provision Delivering a service Included Considered affordable, practical, potentially effective,
potentially acceptable, should have limited side effects
and shouldn’t create significant issues of equity
APEASE Affordability, practicality, effectiveness/cost-effectiveness, acceptability, side effects, equity, UK United Kingdom
aDefinitions from Michie, S., L. Atkins, and R. West, The Behaviour Change Wheel: A Guide to Designing Interventions. 2014, UK: Silverback Publishing
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components will be possible, something highlighted as
important in behaviour change intervention develop-
ment and reporting [38].
This approach to intervention development (use of
TDF, BCW and APEASE) has focused the identification
of intervention functions through which BCTs will be
delivered (Education, Persuasion, Training, Environmen-
tal Restructuring and Enablement). It has also identified
the most likely effective BCTs that could be delivered in
intervention (for example, information about health con-
sequences, use of a credible source, self-monitoring of the
behaviour, social support (emotional), identifying the
pros and cons to taking medications and using habit for-
mation). The effectiveness of these BCTs has been sup-
ported in previous research discussed below. A
Cochrane review, focused on effectiveness of medication
adherence interventions, reported that information, re-
minders and self-monitoring were included in almost all
interventions that showed good effect for improvement
in adherence [39]. In 2016, Conn and colleagues [40]
conducted a meta-analysis, assessing blood pressure out-
comes for medication adherence interventions among
adults with hypertension. It was found that BCTs fo-
cused on habit formation were effective at improving
diastolic blood pressure (habit d = 0.477; no habit d =
0.181; p < .001) [39]. Moreover, O’Carroll and colleagues
[41] piloted a randomised controlled trial (RCT), testing
an intervention (incorporating components to support
habit formation) targeting adherence to antihypertensive
medications in stroke survivors. Significant results were
reported, with 10% more doses taken on schedule in the
intervention group (intervention, 97%; control, 87%;
[95% CI for difference 0.2,16.2]; p = 0.048), encompass-
ing BCTs such as action planning [41].
This study highlights a key methodological challenge
of applying the TDF and BCW in intervention design:
selection of suitable BCTs to target underlying theor-
etical domains was less systematic than identification
of intervention functions and policy categories. How-
ever, work in 2015 by Cane and colleagues [28] and
previous mapping working in 2008 by Michie and col-
leagues [27] assisted in this process, giving some sup-
port and guidance as to which BCTs are likely to
target underlying theoretical domains. The use of this
literature, along with wider reading of BCTs that are
better suited to certain intervention functions and
consideration of BCTs that have been previously re-
ported to show reasonable effect in interventions tar-
geting similar behaviours, has been useful in guiding
BCT selection.
Table 3 Identification of the possible BCTs that could be used in the intervention




1. Feedback on outcome(s) of the behaviour (2.7)
2. Provide normative information about others behaviour/
experiences (BM5)
3. Information about health consequences (5.1)
4. Self-monitoring of behaviour (2.3)
5. Provide reassurance (RC10)
6. Feedback on behaviour (2.2)
7. Biofeedback (2.6)
8. Information about antecedents (4.2)
Beliefs about consequences Education
Persuasion
1. Information about health consequences (5:1)
2. Credible source (9:1)
3. Self-monitoring of outcome(s) of behaviour (2.4)
4. Information about antecedents (4.2)
5. Pros and cons (9.2)
6. Salience of consequences (5.2)
7. Information about social and environmental
consequences (5.3)
8. Information about emotional consequences (5.6)
9. Anticipated regret (5.5)




1. Information about health consequences (5.1)
2. Credible source (9.1)
3. Prompts/cues (7.1)
4. Action planning (1.4)
5. Habit formation (8.3)
6. Self-monitoring of behaviour (2.3)
7. Feedback on behaviour (2.2)
8. Feedback on outcome(s) of the behaviour (2.7)
9. Social support (emotional) (3.3)
10. Reduce negative emotions (11.2)
BCT Behaviour Change Technique, BM5 BCT code relating to a specific focus on the target behaviour (B) and maximising motivation (M), TDF Theoretical
Domains Framework
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Table 4 List of included/excluded BCTs with reasons for inclusion/exclusion
BCTs Reasons for Inclusion/exclusion (against APEASE criteria)
BCTs Included
Information about health consequences (5.1) Considered affordable, practical, potentially effective, potentially acceptable (for patients and
HCPs), should have limited side effects
Self-monitoring of behaviour (2.3) Considered affordable, practical, potentially effective, potentially acceptable (for patients and
HCPs), should have limited side effects and shouldn’t create significant issues of equity
Biofeedback (2.6) Considered affordable (as patients’ blood pressure and cholesterol, for example, are often
monitored and discussed within routine care), practical, potentially effective and potentially
acceptable (for patients and HCPs)
Information about antecedents (4.3) Considered affordable, practical, potentially effective, potentially acceptable (for patients and
HCPs), should have limited side effects and shouldn’t create significant issues of equity
Credible source (9:1) Considered affordable, practical, potentially effective, potentially acceptable (for patients and
HCPs), should have limited side effects and shouldn’t create significant issues of equity
Self-monitoring of outcome(s) of behaviour
(2.4)
Considered affordable (as patients can access, for example, blood pressure monitors for free from
local GP surgeries and pharmacists), practical, potentially effective and potentially acceptable
(for patients and HCPs)
Pros and cons (9.2) Considered affordable, practical, potentially effective and potentially acceptable (for patients
and HCPs)
Prompts/cues (7:1) Considered affordable, practical, potentially effective, potentially acceptable (for patients and
HCPs), should have limited side effects and shouldn’t create significant issues of equity
Action planning (1:4) Considered affordable, practical, potentially effective, potentially acceptable (for patients and
HCPs), should have limited side effects and shouldn’t create significant issues of equity
Habit formation (8:3) Considered affordable, practical, potentially effective, potentially acceptable (for patients and
HCPs), should have limited side effects and shouldn’t create significant issues of equity
Social support (emotional) (3.3) Considered affordable (as patients may be able to get this support from their own social networks
or from community stroke support groups already running), practical, potentially effective, potentially
acceptable (for patients and HCPs), should have limited side effects
BCTs Excluded
Feedback on outcome(s) of the behaviour
(2.7)
Not considered practical as most feedback on behavioural outcomes (for stroke medication
adherence) routinely provided in NHS is a form of biofeedback and so would add additional
workload if HCPs were providing feedback
Feedback on behaviour (2.2) Not considered practical in this context. Although HCPs based in primary care/community
pharmacy have access to prescription acquisition records, this is a proxy measure of adherence
and so could be difficult to provide accurate estimates of adherence. Even if stroke survivors
provided self-reported accounts of adherence to HCPs/carers and adherence rates were fed back
this could be too onerous as an intervention strategy
Provide normative information about others
behaviour/ experiences (BM5)
Not considered practical to deliver. BCT originally utilised for smoking cessation. The impact of
stroke and varying medication regimens will make generalised comparisons challenging
Salience of consequences (5.2) Not considered practical for negative consequences of non-adherence e.g. use images of the con
sequences of stroke - hard to demonstrate paralysis, aphasia and other stroke implications in an
image. Potential to have unwanted side effects also, if BCT evokes upsetting emotional responses.
Enhancing view about positive consequences of adherence may not be considered acceptable as
patient could have suffered a stroke even when adherent to medication and may not find the
salience of the consequences meaningful
Information about social and environmental
consequences (5.3)
Not considered acceptable. Potential ethical issues. E.g. informing patients that it’s not socially
acceptable to miss medication doses – patients can have valid reasons for not taking medications
Information about emotional consequences
(5.6)
Not considered acceptable and could cause unwanted side effects if information about negative
emotions is given. Provision of this information could be upsetting, and patients can have valid
reasons for not taking medications so seems inappropriate in this context. Even if provide information
about positive emotions (e.g. taking medicines give peace of mind) may not be considered
acceptable to those who have suffered a stroke even when adherent to medication and so may
not find the information meaningful
Anticipated regret (5.5) Not considered acceptable and could cause unwanted side effects. Provision of this information
could be upsetting, and patients can have valid reasons for not taking medications so seems
inappropriate in this context. If a patient suffered a stroke following good adherence to medications
BCT could be considered unacceptable by intervention facilitators delivering this BCT
Comparative imagining of future outcomes
(9.3)
Not considered acceptable. Asking people to imagine different outcomes might not be something
HCPs are confident doing or patients are familiar with
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Strengths and limitations
Strengths
A key strength of this work was the application of the
APEASE evaluative criteria to refine selection of inter-
vention functions, policy categories and BCTs. The mul-
tiple dimensions covered by the tool lead to a more
careful consideration of the realities of implementing
this intervention in the NHS context. For example, the
APEASE criteria remind intervention designers to con-
sider not only potential acceptability but also potential
side effects and the equity implications of a new inter-
vention. As advocated in the literature (e.g. [15, 23]), the
present study also demonstrates a transparent and expli-
cit approach to intervention development. In addition,
the research team came from multidisciplinary back-
grounds (primary care; health psychology) and two of
the three authors were also members of an
internationally-recognised applied stroke care research
group, factors which enabled a more holistic decision
making process when attempting to narrow down selec-
tion of BCTs. Input from the health psychologists, who
have advanced training on the TDF and intervention de-
velopment applying the BCW facilitated effective use of
theory to underpin intervention design.
The generalisability of this study warrants discussion.
The overarching method for medication adherence
intervention development applied here is generalisable
across patient populations. The systematic review to
identify psychological influences on stroke survivors’ ad-
herence included papers from any country and so pro-
vides an internationally applicable view of the factors
that medication adherence interventions for stroke sur-
vivors should target. The ability of particular BCTs to
change psychological influences is considered to be gen-
eric across contexts, in the absence of evidence to the
contrary. Therefore, the initial selection of intervention
components that could alter psychological determinants
of medication adherence is generalisable across stroke
survivors in different contexts. However, the application
of the APEASE criteria to narrow the choice of potential
intervention components requires one to consider both
a specific patient population and context. By explicitly
stating our judgements of each intervention component,
such as a BCT, vs. the APEASE criteria for stroke
survivors within the NHS, we enable others to judge the
extent to which our final BCT selection would generalise
to interventions for stroke survivors in other countries
and contexts.
Limitations
One limitation of this research may be that assessment of
intervention components, such as BCTs, using APEASE
criteria involves a certain amount of subjectivity. However,
the assessment of potential intervention components were
carried out by a multidisciplinary team who have consid-
erable experience and knowledge of adherence interven-
tions and the current healthcare system as it relates to
stroke survivors within the UK.
Stroke survivors are a highly diverse patient group,
with varying impairments as a result of their strokes,
and often significant comorbidities. Our intervention is
intended to support stroke survivors who live in the
community with some degree of independence, rather
than those in institutional care or who are highly
dependent on domiciliary carers. Some stroke survivors
may have considerable dysphasia. Our intervention is
unlikely to entirely meet their needs, and instead, tar-
geted adherence support from doctors, nurses or phar-
macists, tailored to the individual’s particular
communication difficulties (e.g. expressive or recep-
tive), may be required.
A further potential limitation, and subsequent avenue
for future research is the applied definition of adherence
the authors have used. There are varying terms used
interchangeably to describe a multitude of medication
use behaviours including concordance, persistence and
adherence. Research efforts have recently provided a
more testable and analysable definition [42], that opera-
tionalises adherence into three quantifiable stages: initi-
ation, implementation and discontinuation [42]. Our
research focuses on the implementation stage, as many
stroke survivors initiated some of their medications (e.g.
antihypertensives) prior to their stroke. However, in the
future, interventions could be designed to have compo-
nents tailored to target stroke survivors in the three dif-
ferent phases of medication adherence. Most recently, a
new metric for medication adherence measurement has
been proposed that allows these aspects of behaviour to
Table 4 List of included/excluded BCTs with reasons for inclusion/exclusion (Continued)
BCTs Reasons for Inclusion/exclusion (against APEASE criteria)
Reduce negative emotions (11.2) Not considered practical and potentially not affordable. Not all patients would require this
type of BCT and training in stress management, for example, would be costly and time/
labour intensive
Provide reassurance (RC10) Not considered practical. Patients experiences (e.g. of side effects) are likely not time limited
and may vary person to person. Reassurance may not always be the appropriate response
and so may not be considered acceptable
APEASE Affordability, practicality, effectiveness/cost-effectiveness, acceptability, side effects, equity, BCT Behaviour Change Technique, BCTTV1 Behaviour Change
Technique Taxonomy Version 1, HCPs Healthcare Professionals
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be assessed by one measure [43]. However, this metric
was derived from a sample of patients using inhalers and
considers nonadherence related issues such as inhaler
technique. Technique may be less relevant medications
prescribed for stroke risk factor control and as such re-
quires further research in this population. Enhancing as-
sessment of adherence will strengthen evaluations of
intervention effectiveness.
Work such as the establishment of the links between
theoretical domains of the TDF and BCTs is relatively
new, and is based on hypothesised links and expert con-
sensus. Therefore, more work is required to provide em-
pirical, experimental evidence showing that behaviour
change is possible through delivery of specific BCTs tar-
geting underlying determinants known to influence the
behaviour. However, careful exploration of the literature
to identify BCTs, alongside pragmatic decision making
from a multidisciplinary team regarding suitable BCTs
based on evaluative criteria, should enable a more realis-
tic and theory-driven approach.
Future research
The next stage of this project will be to explore the ac-
ceptability of the proposed intervention components, as
well as potential modes of delivery (face-to-face, phone,
text, email, website etc.) with key stakeholders (health-
care professionals (HCPs)and stroke survivors). Explor-
ation of the most acceptable way to operationalise the
BCTs and the acceptability of the overall BCT will be
undertaken. For example, the BCT Action planning will
be considered. This BCT could be operationalised as
asking a participant to make a plan about exactly when
and where they will take their first daily dose of medica-
tion, and interviews will explore the acceptability and
utility of this. Consideration of how this BCT should be
delivered (e.g. in a face-to-face discussion with a HCP,
developed over the phone with a HCP, through develop-
ment of the plans prompted via email) will also be ex-
plored in this study.
Conclusions
Use of the BCW and application of the APEASE cri-
teria, to assess the intervention development in context
(the NHS) has enabled a novel and practical interven-
tion to be developed, targeting medication adherence in
stroke survivors. Previous research identified three key
TDF domains to underpin this intervention design (‘Be-
liefs about consequences’, ‘Knowledge’ and ‘Emotions’).
APEASE criteria supported refinement of potential
intervention components. Five (5/9) intervention func-
tions and five (5/7) policy categories were identified as
possible intervention options. Eleven BCTs, from an
initial list of 21, including habit formation, information
about health consequences and prompts/cues were
considered potentially effective. Feasibility testing is
now underway to explore the perceived acceptability of
the potential intervention components, together with
perceived optimal modes of intervention delivery,




effectsequity; BCT: Behaviour Change Technique; BCTTV1: Behaviour Change
Technique Taxonomy Version 1; BCW: Behaviour Change Wheel; GP: General
practitioner; HCP: Healthcare professional; MRC: Medical Research Council;
MUR: Medication Use Review; NHS: National Health Service; RCT: Randomised
controlled trial; TDF: Theoretical Domains Framework; TIDieR: Template for
intervention description and replication; UK: United Kingdom
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